All products will contain ProBiora3, the Company’s patented proprietary blend of three probiotics purposely designed for oral health.
Oragenics president and CEO John Bonfiglio said the agreement reinforces Oragenics’ strategy to continue to expand the oral probiotic product line in the international market.
"We are confident that in concert with Central Business USA, we can develop a substantial market in these four countries," Bonfiglio added.
Central Business USA provides prescription medication, medical products, vitamins and supplements to the US and South American market.